Literature DB >> 3467338

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists.

G M Mawe, T A Branchek, M D Gershon.   

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) has been shown to be a neurotransmitter in the enteric nervous system (ENS). Although 5-HT is a mediator of slow excitatory postsynaptic potentials evoked by stimulation of interganglionic connectives, the precise role it plays in the physiology of the gut is unclear. Research has been hampered by an inadequate knowledge of the types of 5-HT receptor in the ENS and thus the lack of well-characterized antagonists. We now report the identification of two classes of enteric neural 5-HT receptor, the effects of activating these receptors on myenteric type II/AH neurons, and their characterization with specific agonists and antagonists. One class, which we propose to call 5-HT1P, is characterized by a high affinity for [3H]5-HT in radioligand binding assays. This class of receptor mediates a slow depolarization of myenteric type II/AH neurons associated with an increase in input resistance. Agonists at this receptor include, in addition to 5-HT (in order of potency), 5- and 6-hydroxyindalpine and 2-methyl-5-HT. 5-HT1P-mediated responses are specifically antagonized by 5-hydroxytryptophyl-5-hydroxytryptophan amide. The other class of 5-HT receptor, which we propose to call 5-HT2P, appears not to have a high affinity for [3H]5-HT. This receptor mediates a brief depolarization of myenteric II/AH neurons associated with a fall in input resistance. 2-Methyl-5-HT, at low concentrations, is a specific agonist at this receptor and ICS 205-930 is a specific antagonist. Binding of [3H]5-HT to enteric membranes is inhibited by 5-HT1P receptor agonists and antagonists but not by the 5-HT2P receptor antagonist ICS 205-930 or by MDL 72222, another compound reported to be an antagonist of 5-HT at peripheral receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467338      PMCID: PMC387229          DOI: 10.1073/pnas.83.24.9799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity.

Authors:  E BULBRING; R C LIN
Journal:  J Physiol       Date:  1958-03-11       Impact factor: 5.182

2.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

3.  Serotonergic activation of tonic-type enteric neurons in guinea pig small bowel.

Authors:  J D Wood; C J Mayer
Journal:  J Neurophysiol       Date:  1979-03       Impact factor: 2.714

4.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

5.  Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart.

Authors:  J R Fozard; A T Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

6.  Slow synaptic potentials in neurones of the myenteric plexus.

Authors:  S M Johnson; Y Katayama; R A North
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

7.  Direct evidence of acetylcholine releasing effect of serotonin in the Auerbach plexus.

Authors:  V Adám-Vizi; E S Vizi
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

9.  Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment.

Authors:  M Costa; J B Furness; A C Cuello; A A Verhofstad; H W Steinbusch; R P Elde
Journal:  Neuroscience       Date:  1982-02       Impact factor: 3.590

10.  125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells.

Authors:  K A Yagaloff; P R Hartig
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

View more
  38 in total

1.  Slow excitatory synaptic potentials evoked by distension in myenteric descending interneurones of guinea-pig ileum.

Authors:  P D J Thornton; J C Bornstein
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

2.  Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

Authors:  Fabrizio De Ponti; Francesca Crema
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

3.  Peristalsis evoked by 5-HT and renzapride: evidence for putative 5-HT4 receptor activation.

Authors:  D A Craig; D E Clarke
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 4.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

5.  Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.

Authors:  Johannes Kapeller; Dorothee Möller; Felix Lasitschka; Frank Autschbach; Ruud Hovius; Gudrun Rappold; Michael Brüss; Michael D Gershon; Beate Niesler
Journal:  J Comp Neurol       Date:  2011-02-15       Impact factor: 3.215

6.  5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones.

Authors:  R A North; N Uchimura
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

7.  Activation and desensitization of the 5-HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell.

Authors:  J L Yakel; X M Shao; M B Jackson
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

Review 8.  Physiology and pathophysiology of colonic motor activity (1).

Authors:  S K Sarna
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

9.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

10.  Characterization of 5-hydroxytryptamine receptors mediating mucosal secretion in guinea-pig ileum.

Authors:  P J Johnson; J C Bornstein; J B Furness; D J Woollard; S L Orrman-Rossiter
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.